Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Iceland moss component displays anti-H. pylori activity in vitro

Jan. 31, 1997

Yuhan hepatoprotectant in phase II

Jan. 29, 1997

Antiulcer agents from Otsuka

Jan. 29, 1997

Promising new Sawai antiulcer drug shows excellent results in rats

Jan. 27, 1997

Development of Hepagene progresses

Jan. 27, 1997

Combination therapy for HCV

Jan. 27, 1997

Axcan/Schwarz U.S. joint venture formed

Jan. 22, 1997

Yamanouchi reports 5-HT3 agonists for GI indications

Jan. 22, 1997

GI motility stimulants reported by Janssen

Jan. 22, 1997

Synsorb product enters clinical trials

Jan. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...